[1]董 艳.重组人干扰素α2b阴道泡腾胶囊治疗 宫颈人乳头瘤病毒感染的临床研究[J].医学信息,2018,31(14):147-149.[doi:10.3969/j.issn.1006-1959.2018.14.045]
　DONG Yan.Clinical Study of Recombinant Human Interferon α2b Vaginal Effervescent Capsule in the Treatment of Human Papillomavirus Infection[J].Journal of Medical Information,2018,31(14):147-149.[doi:10.3969/j.issn.1006-1959.2018.14.045]
点击复制

重组人干扰素α2b阴道泡腾胶囊治疗 宫颈人乳头瘤病毒感染的临床研究()

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年14期
页码:
147-149
栏目:
药物与临床
出版日期:
2018-07-15

文章信息/Info

Title:
Clinical Study of Recombinant Human Interferon α2b Vaginal Effervescent Capsule in the Treatment of Human Papillomavirus Infection
文章编号:
1006-1959（2018）14-0147-03
作者:
董 艳
青海红十字医院妇产科，青海 西宁 810000
Author(s):
DONG Yan
Department of Obstetrics and Gynecology,Qinghai Red Cross Hospital,Xining 810000,Qinghai,China
关键词:
重组人干扰素α2b阴道泡腾胶囊; HPV感染; 不良反应
Keywords:
Key words：Recombinant human interferon α2b vaginal effervescent capsule; HPV infection; Adverse reactions
分类号:
R711.74
DOI:
10.3969/j.issn.1006-1959.2018.14.045
文献标志码:
A
摘要:
目的 研究重组人干扰素α2b阴道泡腾胶囊治疗宫颈人乳头瘤病毒感染的临床疗效。方法 选取我院2016年3月~2017年3月收治的96例HPV感染患者，采用随机数字表法将其分为实验组与参照组，各48例。实验组患者采用重组人干扰素α2b阴道泡腾胶囊治疗，参照组患者采用复方沙棘籽油栓治疗，对比两组患者的HPV转阴率、治疗有效率及HC2值，并观察不良反应。结果 实验组患者的HPV转阴率为87.23%，高于参照组的33.33%，差异具有统计学意义（P＜0.05）。实验组患者的宫颈糜烂面治疗总有效率为91.67%，高于参照组的75.00%，差异具有统计学意义（P＜0.05）。疗程结束1个月时，两组的HC2值比较，差异无统计学意义（P＞0.05）；实验组患者在3个月、6个月后的HC2值低于参照组，差异具有统计学意义（P＜0.05）。两组患者的不良反应比较，差异无统计学意义（P＞0.05）。结论 应用重组人干扰素α2b阴道泡腾胶囊治疗HPV感染，对促使HPV转阴、缩小宫颈糜烂面均有积极作用，且不良反应少、安全性高。
Abstract:
Abstract：Objective To study the clinical efficacy of recombinant human interferon α2b vaginal effervescent capsule in the treatment of human papillomavirus infection.Methods 96 patients with HPV infection who were admitted to our hospital from March 2016 to March 2017 were randomly divided into experimental group and reference group,48 cases each.Patients in the experimental group were treated with recombinant human interferon α2b vaginal effervescent capsule,and patients in the reference group were treated with compound seabuckthorn seed oil suppository.The HPV conversion rate,treatment efficiency and HC2 value were compared between the two groups,and adverse reactions were observed.Results The HPV conversion rate of the experimental group was 87.23%,which was higher than that of the reference group 33.33%,and the difference was statistically significant(P<0.05).The total effective rate of cervical erosion in the experimental group was 91.67%,which was higher than that in the reference group 75.00%, and the difference was statistically significant(P<0.05).1 months after the end of the course,the HC2 value of the two groups was not statistically significant(P>0.05).The HC2 value of the patients in the experimental group was lower than the reference group in 3 months and 6 months after the treatment,and the difference was statistically significant(P<0.05).There was no significant difference in adverse reactions between the two groups(P>0.05).Conclusion The use of recombinant human interferon α2b vaginal effervescent capsule in the treatment of HPV infection has a positive effect on promoting HPV to negative and narrowing the cervical erosion surface,and has fewer adverse reactions and high safety.

参考文献/References:

[1]张玲,宋华林,曲芃芃,等.高危型人乳头瘤病毒持续感染宫颈局部免疫状态的研究[J].天津医药,2016,44(11):1363-1366. [2]陈晓静,叶菁.阴道局部干扰素应用对宫颈高危型人乳头瘤病毒感染进程影响的临床研究[J].实用妇产科杂志,2016,32(6):450-452. [3]郝云涛,郑小影,赵淑敏,等.重组人干扰素α2b阴道泡腾胶囊结合射频消融术治疗宫颈糜烂合并HPV亚临床感染的临床观察[J].中国药房,2017,28(23):3223-3226. [4]张树丹,李琪,李戈,等.重组人干扰素α2b阴道泡腾胶囊治疗HPV感染的Meta分析[J].中国医药导报,2017,14(31):111-115. [5]吴江,汪宏良,李美霞,等.宫颈腺鳞癌人乳头瘤病毒基因型的分布、临床病理参数对预后的影响[J].中国现代医学杂志,2016,26(1):99-104. [6]陶萍萍,杨宾烈,张爱,等.人乳头瘤病毒16及其变异体感染者宫颈E6、P53、E7和视网膜母细胞瘤蛋白表达研究[J].国际流行病学传染病学杂志,2017,44(5):306-311. [7]宋春丽,韩新彦.抗人乳头瘤病毒生物蛋白敷料联合干扰素治疗宫颈柱状上皮异位合并高危型人乳头瘤病毒的临床疗效观察[J].中国妇幼保健,2016,31(23):4974-4975.

相似文献/References:

[1]李成诚,李 珣,李 明,等.宫颈HPV感染治疗现状[J].医学信息,2018,31(19):40.[doi:10.3969/j.issn.1006-1959.2018.19.014]
　LI Cheng-cheng,LI Xun,LI Ming,et al.Current Status of Treatment of Cervical HPV Infection[J].Journal of Medical Information,2018,31(14):40.[doi:10.3969/j.issn.1006-1959.2018.19.014]
[2]唐菁娟.佛山和广州女性宫颈细胞HPV基因分型分析[J].医学信息,2019,32(12):139.[doi:10.3969/j.issn.1006-1959.2019.12.045]
　TANG Jing-juan.HPV Genotyping Analysis of Female Cervical Cells in Foshan and Guangzhou[J].Journal of Medical Information,2019,32(14):139.[doi:10.3969/j.issn.1006-1959.2019.12.045]
[3]叶恬恬,张 婷,曹陈鑫,等.基于文献可视化分析中医药治疗HPV感染的研究热点及趋势[J].医学信息,2024,37(07):36.[doi:10.3969/j.issn.1006-1959.2024.07.006]
　YE Tian-tian,ZHANG Ting,CAO Chen-xin,et al.Research Hotspots and Trends of Traditional Chinese Medicine in the Treatment of HPV Infection Based on Literature Visualization[J].Journal of Medical Information,2024,37(14):36.[doi:10.3969/j.issn.1006-1959.2024.07.006]
[4]王 敏,买 莉,王佳陪,等.银川地区农村妇女宫颈癌筛查结果分析[J].医学信息,2025,38(07):100.[doi:10.3969/j.issn.1006-1959.2025.07.018]
　WANG Min,MAI Li,WANG Jiapei,et al.Analysis of Cervical Cancer Screening Results of Rural Women in Yinchuan Area[J].Journal of Medical Information,2025,38(14):100.[doi:10.3969/j.issn.1006-1959.2025.07.018]
[5]陈 荣.冷冻治疗联合重组人干扰素α2b凝胶对慢性宫颈炎合并HPV感染的临床效果及对免疫功能的影响[J].医学信息,2026,39(05):127.[doi:10.3969/j.issn.1006-1959.2026.05.022]
　CHEN Rong.Clinical Effect of Cryotherapy Combined with Recombinant Human Interferon α2b Gel on Chronic Cervicitis Complicated with HPV Infection and its Effect on Immune Function[J].Journal of Medical Information,2026,39(14):127.[doi:10.3969/j.issn.1006-1959.2026.05.022]
[6]王 乐,冯亚宏,杜小利,等.基于网络药理学与分子对接探讨复方紫术栓治疗人乳头瘤病毒感染的作用机制[J].医学信息,2026,39(07):29.[doi:10.3969/j.issn.1006-1959.2026.07.006]
　WANG Le,FENG Yahong,DU Xiaoli,et al.Mechanism of Compound Zizhu Suppository in the Treatment of Human PapillomaVirus Infection Based on Network Pharmacology and Molecular Docking[J].Journal of Medical Information,2026,39(14):29.[doi:10.3969/j.issn.1006-1959.2026.07.006]

更新日期/Last Update: 2018-07-15